Mohammad Y. Zaidi

Mohammad Y. Zaidi

Surgical Oncology

5665 Peachtree Dunwoody Road
ErbBldg
Atlanta, GA 30342

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

ASO Visual Abstract: Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases.

ASO Visual Abstract: Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases.

Journal: Annals of surgical oncology

Published: August 17, 2026

Correction: Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer.

Correction: Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer.

Journal: Molecular cancer therapeutics

Published: July 02, 2026

Optimal duration of neoadjuvant chemotherapy prior to CRS ± HIPEC for colorectal cancer: An assessment of survival and postoperative outcomes.

Optimal duration of neoadjuvant chemotherapy prior to CRS ± HIPEC for colorectal cancer: An assessment of survival and postoperative outcomes.

Journal: Surgical oncology insight

Published: April 27, 2026

Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases.

Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases.

Journal: Annals of surgical oncology

Published: March 24, 2026

High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.

High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.

Journal: Cancer research

Published: April 18, 2025

Postoperative outcomes with minimally invasive minor hepatectomy based on ECOG performance status - analysis of multi-institutional database.

Postoperative outcomes with minimally invasive minor hepatectomy based on ECOG performance status - analysis of multi-institutional database.

Journal: Surgical endoscopy

Published: March 17, 2025

Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.

Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.

Journal: Annals of surgical oncology

Published: March 16, 2023

Hepatic artery infusion for unresectable colorectal cancer liver metastases: Palliation and conversion.

Hepatic artery infusion for unresectable colorectal cancer liver metastases: Palliation and conversion.

Journal: Surgery

Published: January 27, 2023

Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.

Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.

Journal: Journal of surgical oncology

Published: September 23, 2022

The Disparity Morbidity and Mortality Conference: A Mechanism to Identify and Remedy Health Care Inequity.

The Disparity Morbidity and Mortality Conference: A Mechanism to Identify and Remedy Health Care Inequity.

Journal: Annals of surgery

Published: July 15, 2022

Contemporary Outcomes of Transduodenal Sphincteroplasty: the Importance of Surgical Quality.

Contemporary Outcomes of Transduodenal Sphincteroplasty: the Importance of Surgical Quality.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Published: February 24, 2022

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent manner.

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent manner.

Journal: JCI insight

Published: September 14, 2021

Showing 1-12 of 56

Last Updated: 09/26/2026